DaVita Inc. (DVA)Healthcare | Medical Care Facilities | Denver, United States | NYSE
235.58 USD
+2.78
(1.194%)
⇧
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 6:23 a.m. EDT
DaVita presents a compelling tension between impressive recent price momentum and significant valuation risks. The stock has rallied strongly over the last two weeks, trading near its fifty-two-week high, supported by robust earnings growth and a healthy free cash flow stream. However, this optimism clashes sharply with insider activity; executives have offloaded tens of millions of dollars in shares recently, signaling a lack of confidence at the top. Furthermore, analysts collectively view the current price as overvalued, with a mean target price well below the current level. While the nine-year price trajectory remains positive, the high debt load and negative book value prevent this from being a fortress balance sheet. For the short term, the technicals favor a slight upside lean, but the insider selling and valuation gap suggest caution. Long-term, the business generates cash, but the capital structure and insider distribution make it a moderate hold rather than a definitive buy. |
| Model | MAE |
|---|---|
| MSTL_70 ✓ | 0.207547 |
| AutoTheta | 0.238556 |
| MSTL | 0.242988 |
| AutoETS | 0.244395 |
| AutoARIMA | 0.244397 |
| MSTL_70_126 | 0.245637 |
| MSTL_126 | 0.278984 |
Forecast horizon: 60 days | Selected: MSTL_70
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 5.61 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.154 |
| Excess Kurtosis | -0.83 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1261.331 |
| Revenue per Share | 194.224 |
| Market Cap | 15,120,702,464 |
| Trailing P/E | 22.70 |
| Forward P/E | 13.68 |
| Beta | 0.88 |
| Profit Margins | 5.65% |
| Website | https://www.davita.com |
As of July 11, 2026, 6:23 a.m. EDT: Speculators are displaying a divided stance. While there is a notable long-term bullish bet with significant open interest in January 2027 calls at the $270 strike, indicating expectations for substantial appreciation, there is also heavy defensive positioning in December 2026 and November 2027 puts at lower strikes ($110, $210). Implied volatility remains elevated at deep strikes, suggesting uncertainty about the path ahead rather than a unified directional conviction.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.6233177 |
| Address1 | 2,000 16th Street |
| All Time High | 239.64 |
| All Time Low | 0.6875 |
| Ask | 0.0 |
| Ask Size | 100 |
| Audit Risk | 9 |
| Average Analyst Rating | 2.8 - Hold |
| Average Daily Volume10 Day | 922,150 |
| Average Daily Volume3 Month | 873,765 |
| Average Volume | 873,765 |
| Average Volume10Days | 922,150 |
| Beta | 0.882 |
| Bid | 0.0 |
| Bid Size | 100 |
| Board Risk | 2 |
| Book Value | -11.415 |
| City | Denver |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 5 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 235.58 |
| Current Ratio | 1.417 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 239.44 |
| Day Low | 233.31 |
| Debt To Equity | 1,261.331 |
| Display Name | DaVita |
| Earnings Call Timestamp End | 1,778,014,800 |
| Earnings Call Timestamp Start | 1,778,014,800 |
| Earnings Growth | 0.435 |
| Earnings Quarterly Growth | 0.212 |
| Earnings Timestamp | 1,778,011,200 |
| Earnings Timestamp End | 1,785,960,000 |
| Earnings Timestamp Start | 1,785,960,000 |
| Ebitda | 2,792,761,088 |
| Ebitda Margins | 0.20186001 |
| Enterprise To Ebitda | 10.557 |
| Enterprise To Revenue | 2.131 |
| Enterprise Value | 29,482,192,896 |
| Eps Current Year | 14.82627 |
| Eps Forward | 17.22168 |
| Eps Trailing Twelve Months | 10.38 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 200.9296 |
| Fifty Day Average Change | 34.650406 |
| Fifty Day Average Change Percent | 0.17245048 |
| Fifty Two Week Change Percent | 62.33177 |
| Fifty Two Week High | 239.64 |
| Fifty Two Week High Change | -4.0599976 |
| Fifty Two Week High Change Percent | -0.016942069 |
| Fifty Two Week Low | 101.0 |
| Fifty Two Week Low Change | 134.58 |
| Fifty Two Week Low Change Percent | 1.3324753 |
| Fifty Two Week Range | 101.0 - 239.64 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 815,149,800,000 |
| Float Shares | 34,176,228 |
| Forward Eps | 17.22168 |
| Forward P E | 13.67927 |
| Free Cashflow | 999,662,976 |
| Full Exchange Name | NYSE |
| Full Time Employees | 78,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.32454 |
| Gross Profits | 4,490,015,232 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.46897998 |
| Held Percent Institutions | 0.52801996 |
| Implied Shares Outstanding | 64,185,000 |
| Industry | Medical Care Facilities |
| Industry Disp | Medical Care Facilities |
| Industry Key | medical-care-facilities |
| Ir Website | http://phx.corporate-ir.net/phoenix.zhtml?c=76556&p=irol-irhome |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,378,684,800 |
| Last Split Factor | 2:1 |
| Long Business Summary | DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. |
| Long Name | DaVita Inc. |
| Market | us_market |
| Market Cap | 15,120,702,464 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_35644 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 756,416,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 14,942,268,000 |
| Number Of Analyst Opinions | 7 |
| Open | 233.35 |
| Operating Cashflow | 2,027,321,984 |
| Operating Margins | 0.13864 |
| Overall Risk | 2 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.72 |
| Phone | 720 631 2100 |
| Pre Market Change | 0.0 |
| Pre Market Change Percent | 0.0 |
| Pre Market Price | 235.58 |
| Pre Market Time | 1,784,020,485 |
| Previous Close | 232.8 |
| Price Eps Current Year | 15.889364 |
| Price Hint | 2 |
| Price To Book | -20.637758 |
| Price To Sales Trailing12 Months | 1.0929242 |
| Profit Margins | 0.056479998 |
| Quick Ratio | 1.283 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 2.75 |
| Region | US |
| Regular Market Change | 2.78 |
| Regular Market Change Percent | 1.19416 |
| Regular Market Day High | 239.44 |
| Regular Market Day Low | 233.31 |
| Regular Market Day Range | 233.31 - 239.44 |
| Regular Market Open | 233.35 |
| Regular Market Previous Close | 232.8 |
| Regular Market Price | 235.58 |
| Regular Market Time | 1,783,972,803 |
| Regular Market Volume | 464,751 |
| Return On Assets | 0.07496 |
| Return On Equity | 0.80981004 |
| Revenue Growth | 0.06 |
| Revenue Per Share | 194.224 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 64,185,000 |
| Shares Percent Shares Out | 0.070700005 |
| Shares Short | 4,540,078 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 4,855,191 |
| Short Name | DaVita Inc. |
| Short Percent Of Float | 0.1383 |
| Short Ratio | 5.4 |
| Source Interval | 15 |
| State | CO |
| Symbol | DVA |
| Target High Price | 270.0 |
| Target Low Price | 145.0 |
| Target Mean Price | 202.14285 |
| Target Median Price | 205.0 |
| Total Cash | 666,545,984 |
| Total Cash Per Share | 10.382 |
| Total Debt | 13,220,841,472 |
| Total Revenue | 13,835,087,872 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 10.38 |
| Trailing P E | 22.695568 |
| Trailing Peg Ratio | 0.7227 |
| Triggerable | 1 |
| Two Hundred Day Average | 148.69395 |
| Two Hundred Day Average Change | 86.88605 |
| Two Hundred Day Average Change Percent | 0.58432806 |
| Type Disp | Equity |
| Volume | 464,751 |
| Website | https://www.davita.com |
| Zip | 80,202 |